Publications by authors named "Sharon Skare"

Claim this Profile
E
Efficacy and safety of olorinab, a full agonist of the cannabinoid receptor 2, for the treatment of abdominal pain in patients with irritable bowel syndrome: Results from a phase 2b randomized placebo-controlled trial (CAPTIVATE).
Lin Chang, Brooks D Cash, Anthony Lembo, David C Kunkel, Brett A English, Sharon Skare

Neurogastroenterol Motil· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved glycemic control with minimal systemic metformin exposure: Effects of Metformin Delayed-Release (Metformin DR) targeting the lower bowel over 16 weeks in a randomized trial in subjects with type 2 diabetes.
Robert R Henry, Juan P Frias, Brandon Walsh, Sharon Skare, John Hemming

PLoS One· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-daily delayed-release metformin lowers plasma glucose and enhances fasting and postprandial GLP-1 and PYY: results from two randomised trials.
Ralph A DeFronzo, John B Buse, Terri Kim, Colleen Burns, Sharon Skare

Diabetologia· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Primary Glucose-Lowering Effect of Metformin Resides in the Gut, Not the Circulation: Results From Short-term Pharmacokinetic and 12-Week Dose-Ranging Studies.
John B Buse, Ralph A DeFronzo, Julio Rosenstock, Terri Kim, Colleen Burns, Sharon Skare

Diabetes Care· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis